In the context of bladder cancer, growing evidence suggests that aberrant Wnt pathway activation plays a crucial role in its pathology [8].A key factor in its activation is the downstream transcription coactivator CTNNB1, and its sustained accumulation in the cytoplasm is critical to the activation of the Wnt pathway [9]. The gene discussed is CTNNB1; the disease is urinary bladder carcinoma.